I was at ASM, I agree with your assessment of LP's performance.
Listen, I've met face to face with LP and most the BOD and key executives several times now. They are fully committed to getting DVax-L to the finish line.
As regards, to LP's presentation skills, it would be nice to have a more flamboyant speaker as the CEO, but as long as the job gets done, who cares!
NWBO is on track to do something that no other biotech company has done, making progress on the one of the deadliest cancers out, even with constant attacks on several different fronts.